Second quarter 2025 total combined company revenue of $42.0 million; Revenue from continuing operations of $21.8 million Announced strategic sale of SomaLogic to Illumina for up to $425 million in ...
First quarter 2025 revenue of $40.8 million 45% reduction in operating loss and 29% improvement in adjusted EBITDA year-over-year Operationalized $10 million more in annual run rate cost reductions, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback